Prior to infection, we verified that CCL19-treated CD4 + T cells exhibited minimal expression of CD69 and CD25, confirming a resting phenotype, whereas cells treated with phytohaemagglutinin (PHA) and interleukin-2 (IL-2) for 24 hours showed robust upregulation of both markers (S4 Fig). The gene discussed is CCL19; the disease is infection.